Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
KOD Kodiak Sciences Inc
- Stocks
- Healthcare
- NASDAQ: KOD
Price (delayed)
$3.5
Market cap
$184.67M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.63
Enterprise value
$207.28M
Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new
Highlights
KOD's debt is down by 6% YoY
Kodiak Sciences's net income has increased by 18% YoY but it has decreased by 8% QoQ
The EPS has grown by 18% YoY but it has contracted by 8% from the previous quarter
The equity has dropped by 55% year-on-year and by 28% since the previous quarter
Kodiak Sciences's quick ratio has plunged by 54% YoY and by 31% from the previous quarter
Key stats
What are the main financial stats of KOD
Market
Valuations
Earnings
Shares outstanding
52.76M
Market cap
$184.67M
Enterprise value
$207.28M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.7
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$199.87M
Net income
-$190.63M
EBIT
-$190.63M
EBITDA
-$163.84M
Free cash flow
-$107.44M
Per share
Balance sheet
Liquidity
EPS
-$3.63
EPS diluted
-$3.63
Free cash flow per share
-$2.04
Book value per share
$2.06
Revenue per share
$0
TBVPS
$5.65
Total assets
$297.91M
Total liabilities
$189.07M
Debt
$167.64M
Equity
$108.84M
Working capital
$111.81M
Debt to equity
1.54
Current ratio
4.62
Quick ratio
4.7
Net debt/EBITDA
-0.14
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-54.2%
Return on equity
-115.7%
Return on invested capital
-61.3%
Return on capital employed
-71.4%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
KOD stock price
How has the Kodiak Sciences stock price performed over time
Intraday
5.11%
1 week
-7.16%
1 month
48.31%
1 year
-6.42%
YTD
-64.82%
QTD
24.78%
Financial performance
How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$199.87M
Net income
-$190.63M
Gross margin
N/A
Net margin
N/A
The operating income has grown by 20% YoY but it has contracted by 7% from the previous quarter
Kodiak Sciences's net income has increased by 18% YoY but it has decreased by 8% QoQ
Price vs fundamentals
How does KOD's price correlate with its fundamentals
Growth
What is Kodiak Sciences's growth rate over time
Valuation
What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
1.7
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 18% YoY but it has contracted by 8% from the previous quarter
The equity has dropped by 55% year-on-year and by 28% since the previous quarter
The stock's P/B is 47% below its 5-year quarterly average of 3.2 but 13% above its last 4 quarters average of 1.5
Efficiency
How efficient is Kodiak Sciences business performance
KOD's return on equity is down by 43% year-on-year and by 30% since the previous quarter
The ROA has contracted by 19% YoY and by 19% from the previous quarter
KOD's ROIC is up by 15% year-on-year but it is down by 12% since the previous quarter
Dividends
What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for KOD.
Financial health
How did Kodiak Sciences financials performed over time
The total assets is 58% greater than the total liabilities
KOD's current ratio has dropped by 54% year-on-year and by 31% since the previous quarter
Kodiak Sciences's quick ratio has plunged by 54% YoY and by 31% from the previous quarter
KOD's debt is 54% higher than its equity
KOD's debt to equity has soared by 108% YoY and by 36% from the previous quarter
The equity has dropped by 55% year-on-year and by 28% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.